“SGLT2 Inhibitors vs. Finerenone for Slowing CKD Progression in Hypertensive Diabetic Patients with Obesity: A Comparative Effectiveness Study”, JAPMI, vol. 2, no. 1, pp. 21–236, Oct. 2024, doi: 10.60087/Japmi.Vol.02.Issue.01.Id.016.